...
首页> 外文期刊>BMC Medical Imaging >Intrapulmonary administration of bone-marrow derived M1/M2 macrophages to enhance the resolution of LPS-induced lung inflammation: noninvasive monitoring using free-breathing MR and CT imaging protocols
【24h】

Intrapulmonary administration of bone-marrow derived M1/M2 macrophages to enhance the resolution of LPS-induced lung inflammation: noninvasive monitoring using free-breathing MR and CT imaging protocols

机译:骨髓内M1 / M2巨噬细胞的肺内给药以增强LPS诱导的肺部炎症的解决:使用自由呼吸MR和CT成像方案的无创监测

获取原文
           

摘要

Background Alveolar macrophages, with their high functional plasticity, were reported to orchestrate the induction and resolution of inflammatory processes in chronic pulmonary diseases. Noninvasive imaging modalities that offer simultaneous monitoring of inflammation progression and tracking of macrophages subpopulations involved in the inflammatory cascade, can provide an ideal and specific diagnostic tool to visualize the action mechanism in its initial stages. Therefore, the purpose of the current study was to evaluate the role of M1 and M2 macrophages in the resolution of lipopolysaccharide (LPS)-induced lung inflammation and monitor this process using noninvasive free-breathing MRI and CT protocols. Methods Bone-marrow derived macrophages were first polarized to M1 and M2 macrophages and then labeled with superparamagnetic iron oxide nanoparticles. BALB/c mice with lung inflammation received an intrapulmonary instillation of these ex vivo polarized M1 or M2 macrophages. The biodistribution of macrophages subpopulations and the subsequent resolution of lung inflammation were noninvasively monitored using MRI and micro-CT. Confirmatory immunohistochemistry analyses were performed on lung tissue sections using specific macrophage markers. Results As expected, large inflammatory areas noninvasively imaged using pulmonary MR and micro-CT were observed within the lungs following LPS challenge. Subsequent intrapulmonary administration of M1 and M2 macrophages resulted in a significant decrease in inflammation starting from 72?h. Confirmatory immunohistochemistry analyses established a progression of lung inflammation with LPS and its subsequent reduction with both macrophages subsets. An enhanced resolution of inflammation was observed with M2 macrophages compared to M1. Conclusions The current study demonstrated that ex vivo polarized macrophages decreased LPS-induced lung inflammation. Noninvasive free-breathing MR and CT imaging protocols enabled efficient monitoring of progression and resolution of lung inflammation.
机译:背景技术据报道,肺泡巨噬细胞具有较高的功能可塑性,可以协调慢性肺部疾病的炎症过程的诱导和消退。提供同时监测炎症进程和追踪炎症级联反应的巨噬细胞亚群的非侵入性成像方式,可以提供理想的和特定的诊断工具,以可视化其初始阶段的作用机制。因此,本研究的目的是评估M1和M2巨噬细胞在脂多糖(LPS)诱导的肺部炎症的消退中的作用,并使用无创自由呼吸MRI和CT方案监测这一过程。方法首先将源自骨髓的巨噬细胞极化为M1和M2巨噬细胞,然后用超顺磁性氧化铁纳米颗粒标记。患有肺部炎症的BALB / c小鼠接受了这些离体极化的M1或M2巨噬细胞的肺内滴注。巨噬细胞亚群的生物分布和随后的肺部炎症的解决是使用MRI和micro-CT无创监测的。使用特定的巨噬细胞标记物对肺组织切片进行了确认性免疫组织化学分析。结果正如预期的那样,LPS攻击后在肺内观察到了使用肺MR和micro-CT无创成像的大炎症区域。随后经肺内给予M1和M2巨噬细胞可导致从72小时开始的炎症显着减少。验证性免疫组化分析确定了LPS引起的肺部炎症的进展,以及随后两个巨噬细胞亚群的减轻。与M1相比,M2巨噬细胞观察到炎症增强。结论当前的研究表明离体极化的巨噬细胞可减少LPS诱导的肺部炎症。无创呼吸的MR和CT成像协议可有效监测肺部炎症的进展和消退。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号